Circulating Exosomal miR-96 as a Novel Biomarker for Radioresistant Non-Small-Cell Lung Cancer

Figure 2

The expression levels of six plasma exosomal microRNAs among NSCLC patients (n = 52) and HVs (n = 45). Expression of (a) exosomal miR-21, (b) exosomal miR-1246, (c) exosomal let-7g, (d) exosomal miR-210, (e) exosomal miR-214, and (f) exosomal miR-96 in patients with NSCLC and HVs.

(a)

(b)

(c)

(d)

(e)

(f)